Videos

This week on MDNN: The Minnesota medical cannabis program returns pain management results, Japan university researchers find a new asthma phenotype, and the ACP butts heads with diabetes organizations on blood glucose guidelines.

This week on MDNN: Opioids fare worse for chronic pain, ACP releases new diabetes guidelines, daclizumab is withdrawm from markets, and the FDA makes moves.

Stay updated on the biggest headlines with MDNN from November 24, 2017.

Stay updated on the biggest headlines with MDNN from November 17, 2017.

Stay updated on the biggest headlines with MDNN from November 10, 2017.

Stay updated on the biggest headlines with MDNN from October 20, 2017.

In honor of Diabetes Awareness Month, the ADA put together video clips of health care professionals pledging to stop diabetes.

Alexander Mauskop, MD, director of the New York Headache Center, discusses the symptoms and causes of hemiplegic migraines.

Dr. Verbalis, Dr. Green, and Dr. Miller explain the effects of hyponatremia and Marilyn Getty describes her experience with the condition.

Nearly 80% of people worldwide who need palliative care do not have access to needed medicine and treatment.

Daniel A. Osman, MD, talks about detecting malignant tumors in patients

A video and animated overview of a laparoscopic surgical technique used in the treatment of GERD.

This video reviews the use of pacemakers, ICDs, and other implantable devices for patients with heart rhythm disorders.

UCSF cardiologist Gregory Marcus, MD, discusses, the causes, prevention, and management of atrial fibrillation.

Video explores current options for managing hypertension and atherosclerosis.

This 10-minute video takes viewers couch-side to learn about the case of a young woman with trouble sleeping.

A smart chip that can measure and stop pain signals from travelling to the brain may be used soon in human trials.

Video diary depicting life with epidermolysis bullosa, a painful and potentially lethal blistering skin condition that affects thousands of children.

See how the introduction of thorazine to the market changed the face of psychiatry practice.